Showing 17,201 - 17,220 results of 43,973 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((a decrease) OR (we decrease)) ))', query time: 0.79s Refine Results
  1. 17201
  2. 17202

    Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes by Gary C. Chan (4794924)

    Published 2018
    “…Over 5.3 ± 1.4 years, mean vBMD decreased in thoracic/lumbar spine, while mean adipose tissue volumes increased in SAT, IMAT, and PAT, but not VAT depots. …”
  3. 17203

    Differential requirements of NMDAR and VDCC for Aβ-induced declustering of Homer1b and Shank1. by Francesco Roselli (211670)

    Published 2009
    “…NMDA alone significantly reduced Homer (75.1±8.8%, p<0.05) and a further decrease was observed after NMDA+Aβ cotreatment (50.2±5.2% of untreated control). …”
  4. 17204
  5. 17205

    FPR1/2/3 expression changes of blood immune cells after 6-month CPAP treatment. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) FPR1 (+) percentage on neutrophil was decreased after > 6-month CPAP treatment. …”
  6. 17206
  7. 17207
  8. 17208
  9. 17209

    DataSheet3_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  10. 17210

    DataSheet2_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  11. 17211

    DataSheet1_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  12. 17212
  13. 17213

    Analyses of directed phase lag index (dPLI [44]) for excitatory/inhibitory (E/I) ratios with respect to pyramidal (Pyr) and parvalbumin (PV) populations (<i>A</i>) and Pyr and soma... by Nobuhiko Wagatsuma (494052)

    Published 2025
    “…<p>Black circles and gray pentagons represent the mean values of dPLI from PV to Pyr and from SOM to Pyr populations, respectively. …”
  14. 17214
  15. 17215

    Docking results of effective compounds in TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  16. 17216

    Active compounds screened from TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  17. 17217

    Network of compound-target-pathway. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  18. 17218
  19. 17219

    Table_1_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.DOCX by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  20. 17220

    Image_1_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.TIFF by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”